IONIS PHARMACEUTICALS INC (IONS) › Cost of RevenueIONIS PHARMACEUTICALS INC (IONS) — Cost of RevenueAnnual figures by fiscal year, from SEC filings.2016: $02017: $02018: $1.82M2019: $4.38M2020: $11.95M2021: $10.84M2022: $14.12M2023: $9.13M2024: $11.21M2025: $15.91M$15.91M2016Cost of Revenue (USD)2025Fiscal YearCost of RevenueChange YoY2025$15.91M+41.9%2024$11.21M+22.8%2023$9.13M-35.3%2022$14.12M+30.2%2021$10.84M-9.2%2020$11.95M+172.5%2019$4.38M+140.9%2018$1.82M—2017$0—2016$0—Other metrics: RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share